Beam Therapeutics Inc. (BEAM) Operating income 2019–2025
Beam Therapeutics Inc. (BEAM) annual operating income history from SEC filings — each fiscal year as reported.
-$383.7MFY2025 · since FY2019: -$75.2M → -$383.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$383.7M | +7.7% |
| FY2024 | -$415.6M | -135.5% |
| FY2023 | -$176.5M | +47.9% |
| FY2022 | -$338.5M | +13.8% |
| FY2021 | -$392.5M | -195.6% |
| FY2020 | -$132.8M | -76.7% |
| FY2019 | -$75.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BEAM financial trends
BEAM RevenueBEAM Net incomeBEAM Net marginBEAM Gross profitBEAM Gross marginBEAM Operating marginBEAM Operating cash flowBEAM Free cash flowBEAM Capital expendituresBEAM Return on equityBEAM Stock buybacksBEAM Dividends paidBEAM Total assetsBEAM Total liabilitiesBEAM Shareholders’ equityBEAM overview →